Quantitation of oxcarbazepine and its metabolites in human plasma by micellar electrokinetic chromatography
- 11 April 2003
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 17 (4), 231-238
- https://doi.org/10.1002/bmc.217
Abstract
A reliable micellar electrokinetic chromatographic method for the determination of oxcarbazepine and its two main metabolites, 10‐hydroxycarbamazepine and 10,11‐trans‐dihydroxy‐10,11‐dihydroxycarbamazepine, in human plasma was developed. The separation and determination of the analytes was achieved using a system consisting of 60 mM SDS in phosphate buffer (30 mM, pH 8.0), to which 20% (v/v) methanol was added. Separation was carried out in an uncoated fused‐silica capillary with a separation voltage of 25 kV and currents typically less than 40 µA. Spectrophotometric detection was at 205 nm. Isolation of oxcarbazepine and its metabolites from plasma was accomplished by a solid‐phase extraction procedure. The mean extraction yield of the analytes from plasma was higher than 94%. The linear correlation coefficients were better than 0.994 for all analytes. The limit of detection was 0.05 µg/mL, the limit of quantitation 0.15 µg/mL. The repeatability for the spiked blank plasma samples was lower than 1.9% and the intermediate precision lower than 2.1%, both expressed as RSD%. The results obtained analysing real plasma samples from epileptic patients under therapy with Tolep® were satisfactory in terms of precision, accuracy and detectability. Copyright© 2003 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Microemulsion electrokinetic chromatography for the separation of carbamazepine, oxcarbazepine, and their metabolitesJournal of Separation Science, 2002
- Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatographyBiomedical Chromatography, 2001
- Oxcarbazepine, an antiepileptic agentClinical Therapeutics, 2001
- Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial EpilepsyEpilepsia, 2000
- Place of Newer Antiepileptic Drugs in the Treatment of EpilepsyDrugs, 1993
- The pharmacokinetics of oxcarbazepine and its active metabolite 10‐hydroxy‐carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acidBritish Journal of Clinical Pharmacology, 1993
- Comparative Pharmacokinetics of the Newer Antiepileptic DrugsClinical Pharmacokinetics, 1993
- OxcarbazepineDrugs, 1992
- Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diolJournal of Mass Spectrometry, 1986
- The metabolism of14C-oxcarbazepine in manXenobiotica, 1986